Revolutionizing MDD diagnosis: the integrated role of circRNAs and biosensor technology

Liu J, Zhu X, Liu Y, Jia F, Yuan H, Wang Q, et al. Association between triglyceride glucose index and suicide attempts in patients with first-episode drug-naïve major depressive disorder. Front psychiatry. 2023;14:1231524.

PubMed 
PubMed Central 

Google Scholar 

Halaris A. A primary care focus on the diagnosis and treatment of major depressive disorder in adults. J Psychiatr Pract. 2011;17:340–50.

PubMed 

Google Scholar 

Gao K, Calabrese JR. Prevalence and factors associated with fatigue in patients with major depressive disorder or bipolar disorder. J Affect Disord. 2024;362:493–501.

PubMed 

Google Scholar 

McIntyre RS, Xiao HX, Syeda K, Vinberg M, Carvalho AF, Mansur RB, et al. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder. CNS drugs. 2015;29:577–89.

CAS 
PubMed 

Google Scholar 

Hopwood M. Anxiety symptoms in patients with major depressive disorder: commentary on prevalence and clinical implications. Neurol Ther. 2023;12:5–12.

PubMed 
PubMed Central 

Google Scholar 

Amin-Esmaeili M, Motevalian A, Rahimi-Movaghar A, Hajebi A, Sharifi V, Mojtabai R, et al. Bipolar features in major depressive disorder: results from the Iranian mental health survey (IranMHS). J Affect Disord. 2018;241:319–24.

PubMed 

Google Scholar 

Xin LM, Chen L, Su YA, Yang FD, Wang G, Fang YR, et al. Prevalence and clinical features of atypical depression among patients with major depressive disorder in China. J Affect Disord. 2019;246:285–9.

PubMed 

Google Scholar 

Sun J, Ma Y, Chen L, Wang Z, Guo C, Luo Y, et al. Altered brain function in treatment-resistant and non-treatment-resistant depression patients: a resting-state functional magnetic…